Diabetic ketoacidosis (DKA) is one of the most serious acute complications of diabetes, carrying significant risks of morbidity and mortality if not recognized and treated promptly. While the classic triad of hyperglycemia, ketonemia, and metabolic acidosis defines DKA, the presence of fever and chills can serve as critical red flags for underlying infection or worsening metabolic derangement. Understanding how these symptoms interact with the pathophysiology of DKA is essential for both patients and healthcare providers to intervene early and prevent life-threatening outcomes.

Understanding Diabetic Ketoacidosis

DKA arises from an absolute or relative insulin deficiency coupled with an excess of counter-regulatory hormones such as glucagon, cortisol, and catecholamines. This hormonal imbalance triggers uncontrolled lipolysis, releasing free fatty acids that the liver converts into ketone bodies—acetoacetate, beta-hydroxybutyrate, and acetone. As ketone levels rise, a metabolic acidosis develops, overwhelming the body’s buffering systems. The resulting acidemia impairs cellular function, depresses myocardial contractility, and can lead to profound electrolyte disturbances.

Typical presenting symptoms include polyuria, polydipsia, nausea, vomiting, abdominal pain, and a characteristic fruity odor on the breath. In more severe cases, patients may develop Kussmaul respirations—deep, rapid breathing—as the lungs attempt to excrete carbon dioxide and compensate for acidosis. Mental status can range from lethargy to coma. Diagnostic criteria for DKA generally include a blood glucose level above 250 mg/dL, a serum bicarbonate level below 18 mEq/L, a pH less than 7.30, and the presence of ketones in blood or urine. However, the severity of DKA depends on the degree of acidosis, with mild cases presenting with pH 7.25–7.30 and severe cases dipping below 7.0.

Infection is the most common precipitating factor for DKA, responsible for roughly one-third of all episodes. Other triggers include insulin omission or dose errors, myocardial infarction, stroke, pancreatitis, trauma, and certain medications such as corticosteroids or sodium-glucose cotransporter-2 (SGLT2) inhibitors. The interplay between infection and DKA creates a vicious cycle: infection increases insulin resistance and counter-regulatory hormone release, worsening hyperglycemia and ketosis, while the metabolic derangements of DKA impair immune function, making the patient more vulnerable to sepsis.

The Connection Between Infection and DKA

Systemic infections—whether bacterial, viral, or fungal—provoke a stress response that directly antagonizes insulin action. Pro-inflammatory cytokines such as tumor necrosis factor-alpha, interleukin-1, and interleukin-6 stimulate the release of glucagon and cortisol, promoting gluconeogenesis and glycogenolysis. Simultaneously, peripheral glucose uptake is reduced due to insulin resistance. The net effect is a rapid rise in blood glucose levels, often exceeding the renal threshold and leading to osmotic diuresis and volume depletion. As dehydration worsens, renal perfusion declines, impairing the excretion of glucose and ketones and perpetuating the cycle.

In patients with Type 1 diabetes, the absence of endogenous insulin production leaves them particularly vulnerable to ketosis during stress. In Type 2 diabetes, especially in those with long-standing disease and beta-cell dysfunction, DKA can also occur, a condition sometimes termed ketosis-prone Type 2 diabetes. Regardless of diabetes type, infection serves as a powerful metabolic stressor that can tip an otherwise compensated state into full-blown DKA.

Fever and chills are classic indicators that the immune system is engaged in fighting an infection. In the context of diabetes, these symptoms should never be dismissed as trivial. Fever raises the basal metabolic rate, increasing glucose utilization but also stimulating hepatic glucose output. Each 1°C rise in body temperature corresponds to approximately a 30–40% increase in metabolic rate, placing added demands on glucose homeostasis. The presence of chills suggests a systemic inflammatory response, often mediated by endogenous pyrogens released from activated immune cells. This response can accelerate ketone production and exacerbate acidosis.

Fever and Chills as Key Warning Signs in DKA

Historically, DKA patients often present with normothermia or even hypothermia due to peripheral vasodilation and impaired thermoregulation. However, when fever and chills do occur, they point strongly toward an infectious etiology that is both precipitating and perpetuating the DKA episode. Studies have shown that fever (temperature ≥38.3°C or 101°F) in DKA is associated with higher rates of bacteremia, longer hospital stays, and increased mortality.

Fever – A Double-Edged Metabolic Stressor

Fever in DKA is more than just a marker of infection; it actively worsens the metabolic milieu. Hyperthermia increases insulin resistance by altering insulin receptor binding and signaling. It also stimulates the release of counter-regulatory hormones, compounding the hyperglycemia and ketogenesis. Furthermore, fever drives fluid loss through sweating and hyperpnea, worsening the dehydration that is already a hallmark of DKA. The combination of volume depletion, acidosis, and infection increases the risk of acute kidney injury, requiring careful monitoring of renal function and electrolyte replacement.

Clinicians should pay particular attention to fever that persists after initial fluid resuscitation and insulin therapy. Persistent pyrexia may indicate an inadequately drained abscess, drug fever, or a resistant pathogen. Blood cultures, urinalysis, chest radiographs, and other appropriate imaging should be obtained early to identify the source. A rising fever accompanied by worsening acidosis or altered mental status demands immediate escalation of care.

Chills – The Body’s Attempt to Generate Heat

Chills are rhythmic, involuntary muscle contractions that generate heat, often occurring in cycles when the body’s thermostat is reset to a higher set point. In DKA, the presence of chills suggests a robust systemic inflammatory response, often linked to bacteremia or severe localized infection such as pneumonia or pyelonephritis. The exaggerated muscle activity not only raises core temperature but also increases oxygen consumption, carbon dioxide production, and metabolic demands—all of which stress an already compromised acid-base balance.

Rigors (severe chills with shaking) are particularly concerning, as they are frequently associated with gram-negative bacteremia or overwhelming sepsis. In patients with diabetes who have impaired neutrophil function, even a minor infection can progress rapidly to bloodstream invasion. Chills that persist beyond the initial presentation may indicate inadequate source control or evolving sepsis.

Recognizing DKA Complications

When fever and chills accompany DKA, the risk of several complications rises sharply. The most important include:

  • Cerebral edema: Primarily seen in children, but also described in adults with severe DKA. Fever may contribute by increasing cerebral blood flow and capillary permeability, raising intracranial pressure. This complication requires emergency intervention with mannitol or hypertonic saline.
  • Acute kidney injury (AKI): Volume depletion compounded by sepsis-induced renal hypoperfusion can lead to AKI. Fever and chills are early signs of a hyperdynamic state that, if uncorrected, may progress to oliguric renal failure.
  • Sepsis and septic shock: The combination of DKA and infection significantly elevates the risk of organ dysfunction. Hypotension, tachycardia, and lactic acidosis may develop rapidly. Fever and chills are among the earliest harbingers of this transition.
  • Hypothermia paradox: Paradoxically, some DKA patients with severe sepsis may be hypothermic on arrival. In these cases, the absence of fever does not rule out infection; chills may be the only clue. Clinicians must maintain a high index of suspicion.

Common Infections That Precipitate DKA

Diabetes predisposes individuals to a broad range of infections due to impaired immune defenses, including defective leukocyte function, reduced complement activity, and compromised microvascular perfusion. The most frequent infections triggering DKA include:

  • Urinary tract infections (UTIs) and pyelonephritis: Due to autonomic neuropathy leading to incomplete bladder emptying, patients with diabetes are at high risk for UTIs. Gram-negative organisms such as E. coli are common. Fever, flank pain, and dysuria should prompt urine culture and imaging.
  • Pneumonia: Both community-acquired and hospital-acquired pneumonia can precipitate DKA. Streptococcus pneumoniae and Staphylococcus aureus are frequent pathogens. Chills and productive cough are concerning signs. Chest X-ray is essential.
  • Skin and soft tissue infections: Diabetic foot infections and cellulitis can quickly become systemic. Fever and chills in a patient with a foot ulcer should raise suspicion for osteomyelitis or necrotizing fasciitis.
  • Intra-abdominal infections: Cholecystitis, diverticulitis, and appendicitis are more common in diabetes. The classic symptoms may be masked by autonomic neuropathy, making fever and chills crucial clues.
  • Mucormycosis: A rare but devastating fungal infection that can affect the sinuses or lungs, especially in patients with ketoacidosis. Fever, facial pain, and black eschars require urgent surgical and antifungal intervention.

Given the breadth of potential infectious causes, a systematic diagnostic approach is needed for any DKA patient with fever and chills. Blood and urine cultures, a complete blood count with differential, inflammatory markers (C-reactive protein, procalcitonin), and imaging as guided by symptoms should be obtained without delay.

Differentiating DKA from Other Conditions Presenting with Fever and Chills

Fever and chills are not exclusive to DKA-related infections. Several other conditions can mimic or coexist with DKA, and the clinician must differentiate them.

  • Hyperosmolar Hyperglycemic State (HHS): While HHS generally presents with extreme hyperglycemia and profound dehydration without significant ketoacidosis, overlap syndromes exist. Fever in HHS is also often due to infection and requires similar management. Measuring beta-hydroxybutyrate helps distinguish the two.
  • Bacteremia without DKA: Patients with diabetes can develop sepsis without underlying ketosis. In such cases, blood glucose may be elevated but not necessarily to DKA thresholds. Checking venous blood gas and ketone levels clarifies the diagnosis.
  • Endocarditis: Sustained fever and chills with new murmurs, splenomegaly, or embolic phenomena should prompt echocardiography. Diabetes is a risk factor for infective endocarditis, especially from S. aureus.
  • Pancreatitis: Acute pancreatitis can cause abdominal pain, nausea, and vomiting similar to DKA, and both conditions raise serum lipase. Fever suggests infected pancreatic necrosis or pseudocyst.

A thorough history, physical examination, and targeted laboratory testing are essential to avoid misdiagnosis and ensure appropriate therapy.

When to Seek Emergency Medical Help

Patients with diabetes and their families must be educated about warning signs that mandate immediate medical attention. The presence of fever and chills in a patient already known to have or developing DKA is an unequivocal signal to access emergency services. The following criteria should prompt the individual to call 911 or go to the nearest emergency department:

  • Fever above 101°F (38.3°C) that does not respond to antipyretics or persists for more than a few hours.
  • Severe shaking chills (rigors), especially if accompanied by confusion or difficulty breathing.
  • Persistent nausea, vomiting, or abdominal pain that prevents oral fluid intake or medication administration.
  • Rapid, deep breathing (Kussmaul respirations) or shortness of breath.
  • Fruity breath odor, a sign of high ketone levels.
  • Altered mental status—drowsiness, confusion, or loss of consciousness.
  • Inability to keep down food or liquids, and blood glucose persistently above 300 mg/dL despite insulin doses.
  • Presence of new or worsening infections such as productive cough, dysuria, or a non-healing wound with surrounding redness.

In-hospital management typically involves aggressive intravenous fluid resuscitation, insulin infusion, and meticulous electrolyte monitoring. If infection is confirmed or strongly suspected, broad-spectrum antibiotics are initiated after cultures are obtained, with later narrowing based on microbiologic results. The goal is to reverse the acidosis, correct volume deficits, and treat the underlying precipitant simultaneously. Early recognition of fever and chills can shorten time to antibiotic administration and improve outcomes.

Prevention and Management Strategies

While DKA is often preventable, the window for intervention narrows when infection and fever are present. Patients should adopt a proactive approach to avoid both DKA and its infectious triggers.

Sick-Day Management for Diabetes

Every patient with diabetes, particularly those on insulin therapy, should have a written sick-day plan. Essential components include:

  • Checking blood glucose every 2–4 hours during illness.
  • Testing urine or blood ketones whenever blood glucose exceeds 250 mg/dL during stress.
  • Continuing insulin even if oral intake is poor. Basal insulin should never be omitted; patients may need additional correction doses.
  • Consuming carbohydrate-containing fluids (e.g., clear juices, regular soda) in small sips if unable to eat solid food. If vomiting persists, medical evaluation is needed.
  • Seeking help early: Do not wait for fever to become high or chills to become severe before contacting a healthcare provider.

Infection Prevention

Immunizations are a cornerstone of preventing infections that can trigger DKA. All adults with diabetes should receive annual influenza vaccines, pneumococcal vaccines, tetanus boosters, and zoster vaccines. For those aged 19–59 with diabetes, the hepatitis B vaccine series is recommended. During the COVID-19 pandemic, staying up to date with SARS-CoV-2 vaccines is also critical, as viral infections are known to precipitate DKA.

Additional preventive measures include good glycemic control (aiming for an A1c below 7% when safe), meticulous foot care, prompt treatment of minor cuts and abrasions, and avoiding cigarette smoking, which exacerbates both infection risk and insulin resistance.

Monitoring and Alertness

Continuous glucose monitoring (CGM) systems can alert patients to hyperglycemic trends before they become dangerous. However, CGM does not replace fingerstick ketone testing during acute illness. Patients should be taught to recognize the early symptoms of DKA—excessive thirst, frequent urination, fatigue, and malaise—and to treat of these signs in the context of fever or chills.

Conclusion

Fever and chills are not merely uncomfortable accompaniments to a common cold; in the setting of diabetes, they can signal the dangerous escalation of DKA complicated by infection. The interplay between hyperglycemia, acidosis, and systemic inflammation creates a volatile clinical environment where minutes matter. By understanding the pathophysiological links, recognizing the high-risk indicators, and knowing when to seek emergency care, both patients and providers can work together to avert catastrophic outcomes. Vigilance, education, and rapid response form the triad that protects individuals with diabetes from the devastating consequences of DKA-associated infections.

For further reading, the American Diabetes Association offers comprehensive guidelines on DKA management (ADA – Diabetic Ketoacidosis). The Centers for Disease Control and Prevention provides detailed information on diabetes-related infections (CDC – Avoiding Infections with Diabetes). Clinicians may also refer to a recent review article discussing fever in DKA (Fever as a Predictor of Infection in DKA – PubMed).